Navigation Links
TRICAST Announces Patent-Pending Technology for Real-Time Health Data Analysis

MILWAUKEE, Jan. 7, 2014 /PRNewswire/ -- TRICAST, Inc., the nation's leading pharmacy data analytics company, today announced the U.S. Patent and Trademark Office's acceptance of their first patent application, a revolutionary low cost, distributed, decentralized and elastically scalable alternative to "Big Data".

"We're excited about our work," explained TRICAST President Greg Rucinski. "It keeps us in step with healthcare reform and the industry's desire for timely reporting."

Response and Intervention Are Concerns
Healthcare Reform business requirements and the Centers for Medicare and Medicaid (CMS) are requiring a responsive approach to managing health care information. Because this has become a top priority, healthcare executives and clinicians are searching for ways to quickly identify and respond to emerging issues. 

Traditional Big Data analysis solutions were developed for organizations requiring a flexible, backward looking analysis of historic data. What of organizations that require immediate insight into data that is not "historic" in the traditional sense, but minutes, or even seconds, old?

The TRICAST Solution
The TRICAST approach couples real-time data streams from disparate sources to its innovative business intelligence software. The resulting real-time analytics allow for the iterative transmission of small amounts of pharmacy and healthcare data and the storage of only the remarkable results—that is, anomalies or oddities or anything the user specifies as out-of-the-ordinary.

"Better, faster, cheaper was our mantra during the development work on this; we can move from problem to solution in real time," adds Rucinski. "This quick, accurate analysis really pays off in the Medicare Part D arena. Turnaround time is critical to the effective management of fraud, waste and abuse and rejected claims monitoring programs, as well as concerns for patient safety."

TRICAST, Inc. is a leading pharmacy data, analytics, and consulting firm founded in 1997. TRICAST has leveraged more than 25 years of technology and claims processing expertise, extensive client insight and a team of industry experts to offer forward-thinking, full-scope pharmacy benefit oversight solutions to its clients. TRICAST provides audit services as the core of its business, and have assessed multiple types of pharmacy programs. The company's broad experience across payers of widely differentiated size and type, combined with focused experience in pharmacy, enabling the delivery of comprehensive assessments of pharmacy programs. Learn more by going to For more information, contact Greg Rucinski at 414.302.9733 or Email.

Read more news from TRICAST.

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. TRICAST Hosts Annual Round Table Assessment of Mid-Market Pharmacy Benefit Managers, Specialty Providers
2. TRICAST Debuts Part D Rejection Oversight Solution for Drug Plan Sponsors
3. Orexigen Announces June 10, 2014 PDUFA Action Date for Contrave
4. Lilly Announces 2014 Financial Guidance, Reconfirms 2013 Expectations
5. Velocity Pharmaceutical Development Announces Appointment of Stuart Sedlack as Senior Vice President, Business Development
6. iHealth Announces Three New Wearable Mobile Personal Health Products At CES 2014
7. Neurocrine Announces Positive Results of VMAT2 Inhibitor NBI-98854 in Kinect 2 Study
8. announces the launch of the 2014 design of the ENTSafety System for tonsil, adenoid and other throat surgeries.
9. Mast Therapeutics Announces Positive Data In Model Of Heart Failure
10. Sequenom Announces Participation At The J.P. Morgan 32nd Annual Healthcare Conference
11. Techne Announces Resignation Of Chief Financial Officer Gregory Melsen
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
Breaking Medicine Technology:
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):